Cencora Inc BRDR C1CO34
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- R$818.40
- Day Range
- R$775.73–775.73
- 52-Week Range
- R$665.32–960.00
- Bid/Ask
- R$0.00 / R$0.00
- Shares Outstanding
- 381.65M
- Market Cap
- R$296.06B
- Volume/Avg
- 2 / 4
Key Statistics
- Price/Earnings (Normalized)
- 17.08
- Price/Sales
- 0.17
- Dividend Yield (Trailing)
- 0.56%
- Dividend Yield (Forward)
- 0.56%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 2.27%
Company Profile
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Mid Core
- Total Number of Employees
- 51,000
- Website
- https://www.cencora.com
Competitors
Valuation
|
Metric
|
C1CO34
|
CAH
|
MCK
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.08 | 21.10 | 23.00 |
Price/Book Value | 18.69 | — | — |
Price/Sales | 0.17 | 0.22 | 0.28 |
Price/Cash Flow | 14.44 | 16.03 | 18.69 |
Price/Earnings
C1CO34
CAH
MCK
Financial Strength
|
Metric
|
C1CO34
|
CAH
|
MCK
|
|---|---|---|---|
Quick Ratio | 0.48 | 0.43 | 0.50 |
Current Ratio | 0.93 | 0.88 | 0.89 |
Interest Coverage | 7.89 | 7.25 | 23.83 |
Quick Ratio
C1CO34
CAH
MCK
Profitability
|
Metric
|
C1CO34
|
CAH
|
MCK
|
|---|---|---|---|
Return on Assets (Normalized) | 4.24% | 4.62% | 5.95% |
Return on Equity (Normalized) | 141.22% | — | — |
Return on Invested Capital (Normalized) | 30.10% | 46.33% | 56.43% |
Return on Assets
C1CO34
CAH
MCK
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|<@$#Mc | LOCK|fH@@t | $109B | |||
| Cencora Inc
COR
| LOCK|xKj<%f | LOCK|?$!CX | $62B | |||
| Cardinal Health Inc
CAH
| LOCK|L%zDB@ | LOCK|?z&^% | $55B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|^X%Ht | $22B | |||
| Henry Schein Inc
HSIC
| LOCK|@!MSLY> | LOCK|s?DP | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|$P | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|kP& | $6B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|%C# | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|&XcL< | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|##v | $4B |
United States